Inhibition of Co-Crystallization of Olmesartan Medoxomil and Hydrochlorothiazide for Enhanced Dissolution Rate in Their Fixed Dose Combination
Crossref DOI link: https://doi.org/10.1208/s12249-018-1207-9
Published Online: 2018-12-17
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdelquader, Magdy M.
Essa, Ebtessam A.
El Maghraby, Gamal M.
Text and Data Mining valid from 2018-12-17
Article History
Received: 27 July 2018
Accepted: 1 October 2018
First Online: 17 December 2018
Compliance with Ethical Standards
:
: The authors declare no conflict of interest.